Red Light Therapy For Tbi

Novel Coronavirus Infectious Diseases Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19)

Pro-inflammatory cytokine storm, acute respiratory distress syndrome (ARDS), multiple organ failure, neurological problems, and thrombosis have all been associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) deaths.

What's the technical parameter of the COZING-C320 red light therapy for tbi?

1.Patients with COVID-19 have elevated levels of many cytokines, including interleukins (IL-1β, IL-2, IL-7, IL-8, IL-9, IL-10, IL-17) and tumor necrosis factor α (TNF-α).

2.Systemic inflammation caused by elevated serum and plasma cytokine levels correlates with the severity of the disease and the likelihood of acute respiratory distress syndrome (ARDS), and cytokine storms continue to be the leading cause of death in COVID-19 patients. Therefore, harnessing the immune system to mitigate this excessive inflammation is critical to the effective management of COVID-19 patients.

3.Thrombosis is becoming an important factor in COVID-19 deaths.Patients with COVID-19, especially in the intensive care unit (ICU), have a high incidence of hypercoagulability in the form of venous and arterial thromboembolism.

4.The most common coagulation event in patients with COVID-19 is a pulmonary embolism (PE), a blood clot in the lungs.A PE restricts blood flow, lowers oxygen levels, and affects other organs, thereby damaging the lungs. organs, thereby damaging the lungs. Large or multiple clots can be fatal.Other thrombotic complications of COVID-19 include venous thromboembolism (VTE), deep vein thrombosis, ischemic stroke, myocardial infarction, and microvascular thrombosis.

Advantages of COZING-C320 for COVID-19 Compared to Medication

1.Non-Invasive and Drug-Free

The COZING-C320 uses 1050nm infrared LED light to stimulate cellular repair and reduce inflammation without the use of pharmaceuticals, eliminating the risk of drug interactions or dependency.

2.Enhances Immune Function

Photobiomodulation therapy promotes mitochondrial activation and increases ATP production, which can boost immune cell performance and support the body's natural defense mechanisms against viral infections like COVID-19.

3.Improves Oxygenation and Circulation

By increasing nitric oxide production and improving microcirculation, the therapy helps to enhance oxygen delivery to tissues, which is critical in respiratory conditions associated with COVID-19.

4.Reduces Inflammation and Oxidative Stress

The targeted 1050nm light penetrates deeply to modulate inflammatory responses and decrease oxidative stress, potentially helping to prevent cytokine storms and lung tissue damage commonly linked to severe COVID-19 cases.

5.No Side Effects

Unlike medications that may cause liver strain, gastrointestinal issues, or allergic reactions, COZING-C320 therapy is painless, non-toxic, and free from systemic side effects, making it suitable for long-term and repeat use.

Principles of COZING-C320 for the treatment of COVID-19

PBMT 1050 nm Efficacy on Cytoprotection, Nitric Oxide (NO) Release, Inflammatory Changes, Improvement of Blood Flow, and Modulation of Heat Shock Protein (Hsp70) Due to the pro-inflammatory and pro-thrombotic properties of COVID-19, Photobiomodulation Therapy (PBMT) can be used to modulate the immune and thrombotic systems and repair damaged host tissues.

The 1050nm PBMT Helmet is a cutting-edge photobiomodulation therapy device designed to enhance recovery from COVID-19 and strengthen immune function. Utilizing 320 high-power 1050nm LEDs with adjustable frequency (1-20,000 Hz), this device delivers deep-penetrating infrared light therapy to:

✔ Reduce inflammation (cytokine storm mitigation)

✔ Boost cellular energy (ATP) for faster recovery

✔ Improve oxygenation & circulation

✔ Support lung tissue repair

✔ Enhance overall immune response

Researchers conducted the first large clinical trial of PBMT for patients with COVID-19 . Despite the small sample size, the study demonstrated that adjunctive PBMT improved the clinical condition of COVID-19 pneumonia, superior to standard medical care. PBMT applied to the lungs (810 nm and 1050 nm) increased peripheral oxygen saturation, relieved pulmonary symptoms, and improved chest X-ray findings. This suggests that PBMT can be used to improve the respiratory and clinical status of COVID-19 patients, reducing the need for ventilatory support and ICU length of stay.

Similarly, a placebo-controlled trial of 30 critically ill COVID-19 patients found that while ICU length of stay did not change between groups, patients treated with 1050/810 nm PBMT-COZING-C320 had reduced diaphragmatic atrophy and improvements in ventilation parameters and lymphocyte counts. a case report by Sigman et al. ( 2020) treated a 57-year-old patient with severe COVID-19 pneumonia using a combination of 808- and 905-nm PBM therapy. After treatment, the patient's radiologic findings, respiratory rate, and oxygen requirements improved significantly without the need for anticipated ventilator therapy. These clinical reports all support the use of PBMT to treat COVID-19 and reduce pressure on health services

Hot Tags: red light therapy for tbi, China red light therapy for tbi manufacturers, suppliers, factory, photo bio modulation therapy, light therapy for brain, red light therapy device for brain, laser photobiomodulation therapy, brain light therapy device, photobiomodulation brain